Effects of partner proteins on BCA2 RING ligase activity

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Bacopulos, Stephanie ^a,b   Amemiya, Yutaka ^a   Yang, Wenyi ^a   Zubovits, Judit ^c   Burger, Angelika ^d   Yaffe, Martin ^a   Seth, Arun K ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; LIGASE;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; TWO HYBRID SYSTEM;

14-3-3 PROTEINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL NUCLEUS; CYTOPLASM; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; EXONUCLEASES; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84862788928     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-63     Document Type: Article

References (45)

1. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, Papas T, Seth A. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998, 16:2459-2467. 10.1038/sj.onc.1201772, 9627112.
2. Burger AM, Gao Y, Amemiya Y, Kahn HJ, Kitching R, Yang Y, Sun P, Narod SA, Hanna WM, Seth AK. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res 2005, 65:10401-10412. 10.1158/0008-5472.CAN-05-2103, 16288031.
3. Toujani S, Dessen P, Ithzar N, Danglot G, Richon C, Vassetzky Y, Robert T, Lazar V, Bosq J, Da CL, et al. High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma. PLoS One 2009, 4:e7089. 10.1371/journal.pone.0007089, 2739276, 19759907.
4. Pray TR, Parlati F, Huang J, Wong BR, Payan DG, Bennett MK, Issakani SD, Molineaux S, Demo SD. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat 2002, 5:249-258. 10.1016/S1368-7646(02)00121-8, 12531181.
5. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 2003, 12:1087-1099. 10.1016/S1097-2765(03)00424-6, 14636569.
6. Duan L, Miura Y, Dimri M, Majumder B, Dodge IL, Reddi AL, Ghosh A, Fernandes N, Zhou P, Mullane-Robinson K, et al. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis. J Biol Chem 2003, 278:28950-28960. 10.1074/jbc.M304474200, 12754251.
7. Amemiya Y, Azmi P, Seth A. Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration. Mol Cancer Res 2008, 6:1385-1396. 10.1158/1541-7786.MCR-08-0094, 2814348, 18819927.
8. Connor MK, Azmi PB, Subramaniam V, Li H, Seth A. Molecular characterization of ring finger protein 11. Mol Cancer Res 2005, 3:453-461. 10.1158/1541-7786.MCR-04-0166, 16123141.
9. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000, 275:8945-8951. 10.1074/jbc.275.12.8945, 10722742.
10. Hu G, Fearon ER. Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins. Mol Cell Biol 1999, 19:724-732. 83929, 9858595.
11. Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 2004, 1695:55-72. 10.1016/j.bbamcr.2004.09.019, 15571809.
12. Jin J, Li X, Gygi SP, Harper JW. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 2007, 447:1135-1138. 10.1038/nature05902, 17597759.
13. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002, 82:373-428.
14. Sakamoto KM. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Mol Genet Metab 2002, 77:44-56. 10.1016/S1096-7192(02)00146-4, 12359129.
15. de Bie P, Ciechanover A. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death Differ 2011, 18(9):1393-1402. 10.1038/cdd.2011.16, 21372847.
16. Burger AM, Kona F, Amemiya Y, Gao Y, Bacopulos S, Seth AK. Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer. Open Cancer J 2010, 3:116-123. 3004234, 21179390.
17. Mizuno K, Kitamura A, Sasaki T. Rabring7, a novel Rab7 target protein with a RING finger motif. Mol Biol Cell 2003, 14:3741-3752. 10.1091/mbc.E02-08-0495, 196564, 12972561.
18. Miyakawa K, Ryo A, Murakami T, Ohba K, Yamaoka S, Fukuda M, Guatelli J, Yamamoto N. BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog 2009, 5:e1000700. 10.1371/journal.ppat.1000700, 2788703, 20019814.
19. Dantuma NP, Heinen C, Hoogstraten D. The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation. DNA Repair (Amst) 2009, 8:449-460.
20. Benzinger A, Muster N, Koch HB, Yates JR, Hermeking H. Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 2005, 4:785-795. 10.1074/mcp.M500021-MCP200, 15778465.
21. Abramoff MD, Magelhaes PJ, Ramm SJ. Image processing wih Image. J Biophotonics Int 2004, 11:36-42.
22. Ortolan TG, Tongaonkar P, Lambertson D, Chen L, Schauber C, Madura K. The DNA repair protein rad23 is a negative regulator of multi-ubiquitin chain assembly. Nat Cell Biol 2000, 2:601-608. 10.1038/35023547, 10980700.
23. Raasi S, Pickart CM. Rad23 ubiquitin-associated domains (UBA) inhibit 26 S proteasome-catalyzed proteolysis by sequestering lysine 48-linked polyubiquitin chains. J Biol Chem 2003, 278:8951-8959. 10.1074/jbc.M212841200, 12643283.
24. Salazar C, Hofer T. Multisite protein phosphorylation-from molecular mechanisms to kinetic models. FEBS J 2009, 276:3177-3198. 10.1111/j.1742-4658.2009.07027.x, 19438722.
25. Kang Y, Vossler RA, Diaz-Martinez LA, Winter NS, Clarke DJ, Walters KJ. UBL/UBA ubiquitin receptor proteins bind a common tetraubiquitin chain. J Mol Biol 2006, 356:1027-1035. 10.1016/j.jmb.2005.12.001, 16405905.
26. Kang Y, Chen X, Lary JW, Cole JL, Walters KJ. Defining how ubiquitin receptors hHR23a and S5a bind polyubiquitin. J Mol Biol 2007, 369:168-176. 10.1016/j.jmb.2007.03.008, 17408689.
27. Watkins JF, Sung P, Prakash L, Prakash S. The Saccharomyces cerevisiae DNA repair gene RAD23 encodes a nuclear protein containing a ubiquitin-like domain required for biological function. Mol Cell Biol 1993, 13:7757-7765. 364847, 8246991.
28. Okamura H, Aramburu J, Garcia-Rodriguez C, Viola JP, Raghavan A, Tahiliani M, Zhang X, Qin J, Hogan PG, Rao A. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell 2000, 6:539-550. 10.1016/S1097-2765(00)00053-8, 11030334.
29. Shen T, Zong C, Hamelberg D, McCammon JA, Wolynes PG. The folding energy landscape and phosphorylation: modeling the conformational switch of the NFAT regulatory domain. FASEB J 2005, 19:1389-1395. 10.1096/fj.04-3590hyp, 16126906.
30. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274. 10.1016/j.cell.2007.06.009, 2756685, 17604717.
31. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997, 1:3-11. 10.1016/S1097-2765(00)80002-7, 9659898.
32. Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000, 275:23106-23112. 10.1074/jbc.M905616199, 10767298.
33. Wilker EW, Grant RA, Artim SC, Yaffe MB. A structural basis for 14-3-3sigma functional specificity. J Biol Chem 2005, 280:18891-18898. 10.1074/jbc.M500982200, 15731107.
34. Li Y, Gazdoiu S, Pan ZQ, Fuchs SY. Stability of homologue of Slimb F-box protein is regulated by availability of its substrate. J Biol Chem 2004, 279:11074-11080. 10.1074/jbc.M312301200, 14707120.
35. Pashkova N, Gakhar L, Winistorfer SC, Yu L, Ramaswamy S, Piper RC. WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins. Mol Cell 2010, 40:433-443. 10.1016/j.molcel.2010.10.018, 3266742, 21070969.
36. Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubinstein YR, Yarden Y, Weissman AM, Lipkowitz S. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J Biol Chem 2001, 276:27677-27684. 10.1074/jbc.M102641200, 11375397.
37. Zeng S, Xu Z, Lipkowitz S, Longley JB. Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Blood 2005, 105:226-232. 10.1182/blood-2004-05-1768, 15315962.
38. Alwan HA, van Zoelen EJ, van Leeuwen JE. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. J Biol Chem 2003, 278:35781-35790. 10.1074/jbc.M301326200, 12829707.
39. Bortezomib (velcade) for multiple myeloma. Med Lett Drugs Ther 2003, 45:57-58.
40. Mitchell BS. The proteasome-an emerging therapeutic target in cancer. N Engl J Med 2003, 348:2597-2598. 10.1056/NEJMp030092, 12826633.
41. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 1999, 4:1029-1040. 10.1016/S1097-2765(00)80231-2, 10635327.
42. Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol Cell 2006, 24:701-711. 10.1016/j.molcel.2006.10.022, 17157253.
43. Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 2005, 20:845-854. 10.1016/j.molcel.2005.12.002, 16359901.
44. Canning M, Boutell C, Parkinson J, Everett RD. A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J Biol Chem 2004, 279:38160-38168. 10.1074/jbc.M402885200, 15247261.
45. Rothenberger S, Burns K, Rousseaux M, Tschopp J, Bron C. Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene 2003, 22:5614-5618. 10.1038/sj.onc.1206497, 12944909.